ID   RUCDRi002-A-5
AC   CVCL_A1PK
SY   TC-1133-CRISPRa; UMGi147-A-5
DR   hPSCreg; RUCDRi002-A-5
DR   Wikidata; Q102114853
RX   PubMed=33038615;
WW   https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=390
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 two constructs one containing CAGpromoter-dCas9-VPR-2A-tdTomato-gGH and the other EF1a-promoter-Pac-SV40polyA were introduced in the AAVS1 safe harbor locus (PubMed=33038615).
CC   Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (with p.Asp10Ala and p.His840Ala = dCas9).
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 9
//
RX   PubMed=33038615; DOI=10.1016/j.scr.2020.101944;
RA   Schoger E., Argyriou L., Zimmermann W.-H., Cyganek L., Zelarayan L.C.;
RT   "Generation of homozygous CRISPRa human induced pluripotent stem cell
RT   (hiPSC) lines for sustained endogenous gene activation.";
RL   Stem Cell Res. 48:101944-101944(2020).
//